Syngene International Ltd logo

Syngene International Ltd

NSE : SYNGENE
BSE: 539268
SECTOR : PHARMACEUTICALS
No data to show from BSE
52w high/low icon
52w high/low
₹700 / ₹490.5
P/E ratio icon
P/E ratio
56.74
Dividend icon
Dividend
0.18
ROE icon
ROE
11.96
ROCE icon
ROCE
11.06
Face value icon
Face value
10
Book value icon
Book value
₹82.02Cr
Market capital icon
Market capital
₹22,345.85Cr

Shareholding pattern

What is shareholding pattern? Who are shareholders?

Shareholding pattern represents the percentage of share ownership that different investors are holding in the company. A company can have multiple investors who invest in its shares. These are called as shareholders and there are two major categories of shareholders - promoters and public shareholders.
Promoters are typically the founders and public shareholders could be financial institutes like banks, insurance companies, domestic institutional investors, foreign institutional investors and common public.

Cash flow

What is a cash flow statement?

It is a financial statement that offers aggregate statistics on all cash inflows a business collects from its continuing activities and external sources of investment. It also includes all cash outflows over a specified time paying for company operations and investments.The main components of the CFS are cash from three areas: operating, investing, and financing activities...Read more

Balance Sheet

What is a balance sheet?

A balance sheet is a financial statement that records the assets, liabilities, and equity of a company at a certain point in time and provides a basis for estimating return rates and determining the capital structure. It offers a snapshot of what an entity owns and owes, as well as the sum that shareholders spend.The balance sheet complies with the following accounting equation in which assets on the one side, and liabilities plus shareholders' equity on the other, balance out:
Assets = Liabilities + Shareholder's Equity
This is used to conduct fundamental analysis or the estimation of financial ratios alongside other essential financial statements, such as income statement and statement of cash flows...Read more

Profit and loss

What is a profit and loss statement?

A profit and loss statement is a financial statement that represents the revenues, costs and expenses that the company has incurred during a quater or a fiscal year. It is also sometimes referred to as statement of profit and loss, income statement or statement of operations. This statement basically shows the investors and management whether the company has incurred profits or losses and in which areas.

Key Ratios

PE TTM
56.74
P/B
6.79
ROE
11.96
ROCE
11.06
Dividend yield
0.18%
EPS TTM
10.35
EBTIDA Growth
5.96
D/E
0.31
Sector PE
34.92
BV
₹82.02Cr

Peer Comparison

Dividends

What are dividends?

Dividend, in financial terms, means a certain amount shared with shareholders of a company or a mutual fund on a regular basis – monthly, quarterly or annually. Read more

Bonuses

What are bonuses?

A bonus issue is an offer given to the existing shareholders of the company to subscribe for additional shares. Instead of increasing the dividend payout, the companies off... Read more

Company News

Sorry, we do not have any data here.

Sector News

Sorry, we do not have any data here.
Syngene International Ltd logo

About Syngene International Ltd

Syngene International Limited is an internationally reputed custom research and manufacturing organisation, which supports R&D programs from lead generation to clinical supplies. The company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited. The company was formed with objectives of providing contract research service to overseas customer in the field of synthetic chemistry, molecular biology and custom synthesis. The company provides integrated services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemicals industries across the world. Syngene's clientele include market leaders such as Bristol-Myers Squibb, Baxter, Amgen, GSK, Zoetis, Merck KGaA and Herbalife. The company was incorporated at Bangalore in the year 1993. During the year 1994-1995, the company pioneered in CRO services for both Chemistry and Biology. During the year 2001-2002, the company acquired a new facility inclusive of a cGMP pilot plant.

Key info

Address
Biocon SEZ Biocon Park, Plot No 2 & 3 Bommasandra Inds, Bengaluru, Karnataka, 560099
Fax Nos.
91-80-28083189
Telephone Nos.
91-80-68915000/67758781
Email
investor@syngeneintl.com
fbtwitterlinkedingithubinstagramyoutube